The plan involves relocating its current test facility in Mississauga, Ont. to the Valleyfield location
MONTREAL—Argex Titanium Inc. has chosen to locate a Research and Development Centre at its recently-announced titanium dioxide (TiO2) production facility in Salaberry-de-Valleyfield, 40 kilometres southwest of Montreal.
Argex says co-locating the facility will garner significant cost savings and benefit from the Quebec government’s tax credit research and development initiatives.
“The Argex R&D Centre will drive ongoing innovation as we continue on the pathway to production,” stated Enrico Di Cesare, Argex’s vice-president of technology and chief operating officer.
“The close integration of our R&D activities with the development of our industrial-scale plant has many operational advantages which we expect will ensure optimal performance at the plant.”
Argex will relocate the operation of its current test facility in Mississauga, Ont. to the Valleyfield location and use it to train operators of the production plant. This move will also significantly increase the TiO2 production capacity of the pilot plant.
“Our R&D Centre will be relied on for continuous improvement as well as to support operations and commissioning of the industrial-sized plant,” said Roy Bonnell, president and CEO of Argex. “Our R&D activities will enable us to focus on the optimization of our production methods in order to meet the highest industry standards as we seek to add value to our TiO2 product.”